Next Article in Journal
Mycobacterium avium Subspecies paratuberculosis: Human Exposure through Environmental and Domestic Aerosols
Next Article in Special Issue
Small Animal Models for Human Metapneumovirus: Cotton Rat is More Permissive than Hamster and Mouse
Previous Article in Journal / Special Issue
Host Pathogen Relations: Exploring Animal Models for Fungal Pathogens
Article Menu

Export Article

Open AccessReview
Pathogens 2014, 3(3), 563-576; doi:10.3390/pathogens3030563

Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment

Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
Current Address: California Institute for Biomedical Research (Calibr), La Jolla, CA 92037, USA.
*
Author to whom correspondence should be addressed.
Received: 15 April 2014 / Revised: 23 June 2014 / Accepted: 23 June 2014 / Published: 3 July 2014
(This article belongs to the Special Issue Animal Model to Study Viral Immunity)
View Full-Text   |   Download PDF [342 KB, uploaded 10 July 2014]   |  

Abstract

CD1d-restricted invariant NKT (iNKT) cells are a group of innate-like regulatory T cells that recognize lipid antigens. Both mouse modeling experiments and human clinical studies have suggested a key role for iNKT cells in anti-HBV immunity and these potent T cells can be explored as a novel therapeutic target for anti-HBV treatment. We aim to humanize mice in the CD1d/iNKT cell lipid presentation system and provide new research tools for identifying novel anti-HBV agents. View Full-Text
Keywords: HBV; NKT; humanized mice; antivirals; immunotherapy HBV; NKT; humanized mice; antivirals; immunotherapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lawrenczyk, A.; Kim, S.; Wen, X.; Xiong, R.; Yuan, W. Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment. Pathogens 2014, 3, 563-576.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top